Hogan Lovells advises Clue on a strategic investment by Verdane

The investment comes from Verdane’s €2 billion growth fund and represents the largest single investment in Clue to date. As part of the transaction, Verdane will become the company’s largest investor.

Founded in 2012 and headquartered in Berlin, BioWink GmbH is the leading provider in the FemTech sector with its application Clue. By turning health data into agency, Clue is building a world where women live better. It is available in 25 languages and in more than 190 countries worldwide.

Verdane is a leading European growth investor that partners with technology-enabled companies to accelerate their scaling. The investor supports teams with capital and operational expertise in the areas of software, digital consumer offerings, and sustainable growth.

Hogan Lovells advised BioWink/Clue on all legal aspects of the transaction.

Hogan Lovells team for BioWink/Clue

Thiemo Woertge (Counsel), Lucie Arntz (Senior Associate), Dr. Dominik Lang (Senior Associate), Julia Dingeldey (Associate), Jasper Lohse (Trainee) (all Corporate/Venture Capital, Munich, Berlin);

Dr. Falk Loose (Counsel), Dr. Marius Plum (Senior Associate) (all Tax, Munich);

Dr. Sebastian Biller (Counsel, Capital Markets, Munich);

Paul Single (Senior Associate, Employment, Frankfurt).